Original language | English (US) |
---|---|
Pages (from-to) | 237-239 |
Number of pages | 3 |
Journal | Journal of Investigative Dermatology |
Volume | 145 |
Issue number | 2 |
DOIs |
|
State | Published - Feb 2025 |
Funding
KQL is the guarantor for this work and will be responsible for addressing any concerns that arise after publication. Research reported in this publication was supported by the National Institutes of Health Chemical Countermeasures Research Program executed by the National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and the National Institutes of Health Office of the Director under award number U54AR079795 (KQL and NCG). The authors disclose that the support for the research described in this study is from a Multidisciplinary Research Program of the University Research Initiative through the Air Force Office of Scientific Research FA 9550-18-1-0142 (NCG) and Northwestern University Skin Biology and Diseases Resource-based Center P30 AR075049. Conceptualization: KQL, NCG; Writing \u2013 Original Draft Preparation: KQL, NCG; Writing \u2013 Review and Editing: KQL, NCG, The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Keywords
- Immunomodulation
- Melanin
- Nanotechnology
- ROS scavenger
- Tissue regeneration
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology
- Dermatology
- Cell Biology